Patents by Inventor Steven Bacich

Steven Bacich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190000610
    Abstract: Intraocular lenses and related assemblies and intraocular attachment methods are disclosed herein. In one embodiment, an intraocular lens assembly comprises a helical-shaped coil fastener to affix an intraocular lens to an iris to correct for astigmatism, presbyopia, and/or myopia or hyperopia. The helical-shaped coil fastener comprises a head and a helical wire extending from a bottom surface of the head and comprising a pointed tip opposite the head. The helical-shaped coil fastener is configured to be affixed to the iris by rotatable penetration of the iris, and thus can be removed from the iris by reverse rotation of the helical-shaped coil fastener. The helical-shaped coil fastener has a low volume, large surface area, low cross-sectional area of penetration, and an oblique angle of penetration. Thus, the helical-shaped coil fastener is easy to apply, easy to remove, minimizes tissue damage, maximizes stability, and minimizes penetration force.
    Type: Application
    Filed: August 15, 2016
    Publication date: January 3, 2019
    Inventors: Timothy R. Willis, Steven Bacich
  • Publication number: 20170299567
    Abstract: A method of treating meibomian gland dysfunction is disclosed. The method includes directing RF energy to an internal portion of a meibomian gland, selectively targeting an obstruction within a duct of the meibomian gland with the applied RF energy to melt, loosen, or soften the obstruction, and expressing the obstruction from the duct of the meibomian gland. An apparatus for treating meibomian gland dysfunction is also disclosed. The apparatus comprises at least one RF electrode configured to direct RF energy to an internal portion of a meibomian gland located in an eyelid of an eye, the at least one RF electrode further configured to selectively target an obstruction within a duct of the meibomian gland with the applied RF energy to melt, loosen, or soften the obstruction. The apparatus also comprises at least one expressor configured to express the obstruction from the duct of the meibomian gland.
    Type: Application
    Filed: June 28, 2017
    Publication date: October 19, 2017
    Inventors: Donald R. Korb, Stephen M. Grenon, Timothy R. Willis, Benjamin Tyson Gravely, Steven Bacich
  • Patent number: 9719977
    Abstract: A method of treating meibomian gland dysfunction is disclosed. The method includes directing RF energy to an internal portion of a meibomian gland, selectively targeting an obstruction within a duct of the meibomian gland with the applied RF energy to melt, loosen, or soften the obstruction, and expressing the obstruction from the duct of the meibomian gland. An apparatus for treating meibomian gland dysfunction is also disclosed. The apparatus comprises at least one RF electrode configured to direct RF energy to an internal portion of a meibomian gland located in an eyelid of an eye, the at least one RF electrode further configured to selectively target an obstruction within a duct of the meibomian gland with the applied RF energy to melt, loosen, or soften the obstruction. The apparatus also comprises at least one expressor configured to express the obstruction from the duct of the meibomian gland.
    Type: Grant
    Filed: August 21, 2012
    Date of Patent: August 1, 2017
    Assignee: TearScience, Inc.
    Inventors: Donald R. Korb, Stephen M. Grenon, Timothy R. Willis, Benjamin Tyson Gravely, Steven Bacich
  • Patent number: 9597224
    Abstract: Contraceptive methods, systems, and devices generally improve the ease, speed, and reliability with which a contraceptive device can be deployed transcervically into an ostium of a fallopian tube. The contraceptive device may remain in a small profile configuration while a sheath is withdrawn proximally, and is thereafter expanded to a large profile configuration engaging the surrounding tissues, by manipulating one or more actuators of a proximal handle with a single hand. This leaves the other hand free to manipulate a hysteroscope, minimizing the number of health care professional required to deploy the contraceptive device.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: March 21, 2017
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Christian Lowe, Donnell Gurskis, Ashish Khera, Monica Sharmane Barnhart Nachbar, Steven Bacich, Betsy Swann, Roberto Silva-Torres
  • Publication number: 20140318549
    Abstract: The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or copper alloy. The device is anchored within the fallopian tube by a lumen-traversing region of the resilient structure which has helical outer surface, together with a portion of the resilient structure which is biased to form a bent secondary shape, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. Optionally, permanent sterilization s effected by passing a current through there resilisent structure to the tubal walls.
    Type: Application
    Filed: May 8, 2014
    Publication date: October 30, 2014
    Applicant: Bayer Essure Inc.
    Inventors: Julian N. Nikolchev, Dai T. Ton, Ashish Khera, Donnell W. Gurskis, Steven Bacich
  • Publication number: 20140216465
    Abstract: Contraceptive methods, systems, and devices generally improve the ease, speed, and reliability with which a contraceptive device can be deployed transcervically into an ostium of a fallopian tube. The contraceptive device may remain in a small profile configuration while a sheath is withdrawn proximally, and is thereafter expanded to a large profile configuration engaging the surrounding tissues, by manipulating one or more actuators of a proximal handle with a single hand. This leaves the other hand free to manipulate a hysteroscope, minimizing the number of health care professional required to deploy the contraceptive device.
    Type: Application
    Filed: April 4, 2014
    Publication date: August 7, 2014
    Applicant: Bayer Essure Inc.
    Inventors: Christian Lowe, Don Gurskis, Ashish Khera, Monica Barnhart, Steven Bacich, Betsy Swann, Roberto Silva-Torres
  • Patent number: 8733361
    Abstract: The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or copper alloy. The device is anchored within the fallopian tube by a lumen-traversing region of the resilient structure which has helical outer surface, together with a portion of the resilient structure which is biased to form a bent secondary shape, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. Optionally, permanent sterilization is effected by passing a current through the resilient structure to the tubal walls.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: May 27, 2014
    Assignee: Bayer Essure Inc.
    Inventors: Julian N. Nikolchev, Dai T. Ton, Ashish Khera, Donnell W. Gurskis, Steven Bacich
  • Patent number: 8733360
    Abstract: The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or copper alloy. The device is anchored within the fallopian tube by a lumen-traversing region of the resilient structure which has helical outer surface, together with a portion of the resilient structure which is biased to form a bent secondary shape, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. Optionally, permanent sterilization s effected by passing a current through there resilient structure to the tubal walls.
    Type: Grant
    Filed: August 20, 2012
    Date of Patent: May 27, 2014
    Assignee: Bayer Essure Inc.
    Inventors: Julian N. Nikolchev, Dai T. Ton, Ashish Khera, Donnell W. Gurskis, Steven Bacich
  • Patent number: 8695604
    Abstract: Contraceptive methods, systems, and devices generally improve the ease, speed, and reliability with which a contraceptive device can be deployed transcervically into an ostium of a fallopian tube. The contraceptive device may remain in a small profile configuration while a sheath is withdrawn proximally, and is thereafter expanded to a large profile configuration engaging the surrounding tissues, by manipulating one or more actuators of a proximal handle with a single hand. This leaves the other hand free to manipulate a hysteroscope, minimizing the number of health care professional required to deploy the contraceptive device.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: April 15, 2014
    Assignee: Bayer Essure Inc.
    Inventors: Christian Lowe, Don Gurskis, Ashish Khera, Monica Barnhart, Steven Bacich, Betsy Swann, Roberto Silva-Torres
  • Patent number: 8613282
    Abstract: The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or copper alloy. The device is anchored within the fallopian tube by a lumen-traversing region of the resilient structure which has helical outer surface, together with a portion of the resilient structure which is biased to form a bent secondary shape, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. Optionally, permanent sterilization is effected by passing a current through there resilisent structure to the tubal walls.
    Type: Grant
    Filed: May 7, 2012
    Date of Patent: December 24, 2013
    Assignee: Conceptus, Inc.
    Inventors: Julian N. Nikolchev, Dai T. Ton, Ashish Khera, Donnell W. Gurskis, Steven Bacich
  • Patent number: 8584679
    Abstract: Contraceptive methods, systems, and devices generally improve the ease, speed, and reliability with which a contraceptive device can be deployed transcervically into an ostium of a fallopian tube. The contraceptive device may remain in a small profile configuration while a sheath is withdrawn proximally, and is thereafter expanded to a large profile configuration engaging the surrounding tissues, by manipulating one or more actuators of a proximal handle with a single hand. This leaves the other hand free to manipulate a hysteroscope, minimizing the number of health care professional required to deploy the contraceptive device.
    Type: Grant
    Filed: February 8, 2012
    Date of Patent: November 19, 2013
    Assignee: Conceptus, Inc.
    Inventors: Christian Lowe, Don Gurskis, Ashish Khera, Monica Barnhart, Steven Bacich, Betsy Swann, Roberto Silva-Torres
  • Publication number: 20130053733
    Abstract: A method of treating meibomian gland dysfunction is disclosed. The method includes directing RF energy to an internal portion of a meibomian gland, selectively targeting an obstruction within a duct of the meibomian gland with the applied RF energy to melt, loosen, or soften the obstruction, and expressing the obstruction from the duct of the meibomian gland. An apparatus for treating meibomian gland dysfunction is also disclosed. The apparatus comprises at least one RF electrode configured to direct RF energy to an internal portion of a meibomian gland located in an eyelid of an eye, the at least one RF electrode further configured to selectively target an obstruction within a duct of the meibomian gland with the applied RF energy to melt, loosen, or soften the obstruction. The apparatus also comprises at least one expressor configured to express the obstruction from the duct of the meibomian gland.
    Type: Application
    Filed: August 21, 2012
    Publication date: February 28, 2013
    Applicant: TearScience, Inc.
    Inventors: Donald R. Korb, Stephen M. Grenon, Timothy R. Willis, Benjamin Tyson Gravely, Steven Bacich
  • Patent number: 8381733
    Abstract: Contraceptive methods, systems, and devices generally improve the ease, speed, and reliability with which a contraceptive device can be deployed transcervically into an ostium of a fallopian tube. The contraceptive device may remain in a small profile configuration while a sheath is withdrawn proximally, and is thereafter expanded to a large profile configuration engaging the surrounding tissues, by manipulating one or more actuators of a proximal handle with a single hand. This leaves the other hand free to manipulate a hysteroscope, minimizing the number of health care professional required to deploy the contraceptive device.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: February 26, 2013
    Assignee: Conceptus, Inc.
    Inventors: Christian Lowe, Don Gurskis, Ashish Khera, Monica Barnhart, Steven Bacich, Betsy Swann, Roberto Silva-Torres
  • Patent number: 8356599
    Abstract: The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or copper alloy. The device is anchored within the fallopian tube by a lumen-traversing region of the resilient structure which has helical outer surface, together with a portion of the resilient structure which is biased to form a bent secondary shape, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. Optionally, permanent sterilizations effected by passing a current through there resilisent structure to the tubal walls.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: January 22, 2013
    Assignee: Conceptus, Inc.
    Inventors: Julian N. Nikolchev, Dai T. Ton, Ashish Khera, Donnell W. Gurskis, Steven Bacich
  • Publication number: 20120312305
    Abstract: The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or copper alloy. The device is anchored within the fallopian tube by a lumen-traversing region of the resilient structure which has helical outer surface, together with a portion of the resilient structure which is biased to form a bent secondary shape, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. Optionally, permanent sterilization s effected by passing a current through there resilient structure to the tubal walls.
    Type: Application
    Filed: August 20, 2012
    Publication date: December 13, 2012
    Inventors: Julian N. Nikolchev, Dai T. Ton, Ashish Khera, Donnell W. Gurskis, Steven Bacich
  • Patent number: 8327852
    Abstract: The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or copper alloy. The device is anchored within the fallopian tube by a lumen-traversing region of the resilient structure which has helical outer surface, together with a portion of the resilient structure which is biased to form a bent secondary shape, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. Optionally, permanent sterilization s effected by passing a current through there resilisent structure to the tubal walls.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: December 11, 2012
    Assignee: Conceptus, Inc.
    Inventors: Julian N. Nikolchev, Dai T. Ton, Ashish Khera, Donnell W. Gurskis, Steven Bacich
  • Publication number: 20120222683
    Abstract: Contraceptive methods, systems, and devices generally improve the ease, speed, and reliability with which a contraceptive device can be deployed transcervically into an ostium of a fallopian tube. The contraceptive device may remain in a small profile configuration while a sheath is withdrawn proximally, and is thereafter expanded to a large profile configuration engaging the surrounding tissues, by manipulating one or more actuators of a proximal handle with a single hand. This leaves the other hand free to manipulate a hysteroscope, minimizing the number of health care professional required to deploy the contraceptive device.
    Type: Application
    Filed: May 10, 2012
    Publication date: September 6, 2012
    Applicant: CONCEPTUS, INC.
    Inventors: Christian Lowe, Don Gurkis, Ashish Khera, Monica Barnhart, Steven Bacich, Betsy Swann, Roberto Silva-Torres
  • Publication number: 20120216817
    Abstract: The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or copper alloy. The device is anchored within the fallopian tube by a lumen-traversing region of the resilient structure which has helical outer surface, together with a portion of the resilient structure which is biased to form a bent secondary shape, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. Optionally, permanent sterilization is effected by passing a current through there resilisent structure to the tubal walls.
    Type: Application
    Filed: May 7, 2012
    Publication date: August 30, 2012
    Inventors: Julian N. Nikolchev, Dai T. Ton, Ashish Khera, Donnell W. Gurskis, Steven Bacich
  • Publication number: 20120145163
    Abstract: Contraceptive methods, systems, and devices generally improve the ease, speed, and reliability with which a contraceptive device can be deployed transcervically into an ostium of a fallopian tube. The contraceptive device may remain in a small profile configuration while a sheath is withdrawn proximally, and is thereafter expanded to a large profile configuration engaging the surrounding tissues, by manipulating one or more actuators of a proximal handle with a single hand. This leaves the other hand free to manipulate a hysteroscope, minimizing the number of health care professional required to deploy the contraceptive device.
    Type: Application
    Filed: February 8, 2012
    Publication date: June 14, 2012
    Applicant: CONCEPTUS, INC., A California Corporation
    Inventors: Christian Lowe, Don Gurskis, Ashish Khera, Monica Barnhart, Steven Bacich, Betsy Swann, Roberto Silva-Torres
  • Patent number: 8171936
    Abstract: The invention provides intrafallopian devices and non-surgical methods for their placement to prevent conception. The efficacy of the device is enhanced by forming the structure at least in part from copper or copper alloy. The device is anchored within the fallopian tube by a lumen-traversing region of the resilient structure which has helical outer surface, together with a portion of the resilient structure which is biased to form a bent secondary shape, the secondary shape having a larger cross-section than the fallopian tube. The resilient structure is restrained in a straight configuration and transcervically inserted within the fallopian tube, where it is released. Optionally, permanent sterilization s effected by passing a current through there resilient structure to the tubal walls.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: May 8, 2012
    Assignee: Conceptus, Inc.
    Inventors: Julian N. Nikolchev, Dai T. Ton, Ashish Khera, Donnell W. Gurskis, Steven Bacich